| scholarly article | Q13442814 |
| P50 | author | Cecilia Giulivi | Q30511277 |
| Andrea Schneider | Q56955657 | ||
| P2093 | author name string | Flora Tassone | |
| Randi Hagerman | |||
| Eleonora Napoli | |||
| Sarah Wong | |||
| Gyu Song | |||
| P2860 | cites work | The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents | Q22305963 |
| Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission | Q24320327 | ||
| Microtubule-associated protein 1S (MAP1S) bridges autophagic components with microtubules and mitochondria to affect autophagosomal biogenesis and degradation | Q24338231 | ||
| HUMMR, a hypoxia- and HIF-1alpha-inducible protein, alters mitochondrial distribution and transport | Q24338481 | ||
| The role of the LRPPRC (leucine-rich pentatricopeptide repeat cassette) gene in cytochrome oxidase assembly: mutation causes lowered levels of COX (cytochrome c oxidase) I and COX III mRNA | Q24528119 | ||
| FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism | Q24631425 | ||
| Mitochondrial dysfunction in neurodegenerative diseases | Q28387647 | ||
| Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis | Q28510836 | ||
| 2000 CDC Growth Charts for the United States: methods and development | Q29614506 | ||
| Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome | Q33570563 | ||
| Neuropathic features in fragile X premutation carriers. | Q51909237 | ||
| Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. | Q51953728 | ||
| FMRP expression as a potential prognostic indicator in fragile X syndrome. | Q51984679 | ||
| Effects of aripiprazole and clozapine on the treatment of glycolytic carbon in PC12 cells. | Q54525405 | ||
| Activities of cytochrome c oxidase and citrate synthase in lymphocytes of obese and normal-weight subjects | Q57847978 | ||
| Diagnosis of mitochondrial disorders: clinical and biochemical approach | Q74017467 | ||
| The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria | Q33638683 | ||
| A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome | Q33652584 | ||
| The metabolic cost of neural information | Q33858019 | ||
| Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. | Q34146206 | ||
| Fragile X and autism: Intertwined at the molecular level leading to targeted treatments | Q34198650 | ||
| Signaling the mitochondrial unfolded protein response | Q34263419 | ||
| Premature ovarian failure in the fragile X syndrome | Q34306135 | ||
| Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. | Q34364858 | ||
| Mitochondrial UPR-regulated innate immunity provides resistance to pathogen infection | Q34735561 | ||
| Mitochondrial threshold effects. | Q35017647 | ||
| Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome | Q35090105 | ||
| Negative and positive regulation of HIF-1: a complex network | Q36182360 | ||
| A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. | Q36329311 | ||
| PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity | Q36350223 | ||
| Critical dependence of neurons on mitochondrial dynamics | Q36509524 | ||
| WHO Motor Development Study: windows of achievement for six gross motor development milestones | Q36525973 | ||
| Maintenance and propagation of a deleterious mitochondrial genome by the mitochondrial unfolded protein response | Q36917773 | ||
| Toxicity of the flame-retardant BDE-49 on brain mitochondria and neuronal progenitor striatal cells enhanced by a PTEN-deficient background | Q36957020 | ||
| Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle | Q37094241 | ||
| Mitochondrion-associated protein LRPPRC suppresses the initiation of basal levels of autophagy via enhancing Bcl-2 stability | Q37186891 | ||
| Developmental profiles of infants with an FMR1 premutation | Q37394408 | ||
| The mitochondrial unfolded protein response, a conserved stress response pathway with implications in health and disease | Q37402149 | ||
| Presynaptic mitochondrial morphology in monkey prefrontal cortex correlates with working memory and is improved with estrogen treatment | Q37475050 | ||
| Mitochondrial dysfunction in autism | Q37558748 | ||
| Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome | Q37580522 | ||
| Hypoxia-inducible factor 1: Regulator of mitochondrial metabolism and mediator of ischemic preconditioning | Q37781873 | ||
| Mitochondria in innate immunity | Q37907827 | ||
| A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture | Q38711762 | ||
| Warburg effect linked to cognitive-executive deficits in FMR1 premutation | Q39661355 | ||
| Elevated levels of autophagy-related marker ULK1 and mitochondrion-associated autophagy inhibitor LRPPRC are associated with biochemical progression and overall survival after androgen deprivation therapy in patients with metastatic prostate cancer | Q40563100 | ||
| Altered Bioenergetics in Primary Dermal Fibroblasts from Adult Carriers of the FMR1 Premutation Before the Onset of the Neurodegenerative Disease Fragile X-Associated Tremor/Ataxia Syndrome | Q41637163 | ||
| Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway | Q42708571 | ||
| Inhibition of mitochondrial respiratory chain in the brain of adult rats after acute and chronic administration of methylphenidate | Q43272191 | ||
| United States head circumference growth reference charts: birth to 21 years | Q44284547 | ||
| Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation | Q44521568 | ||
| Plasma metabolic profile delineates roles for neurodegeneration, pro-inflammatory damage and mitochondrial dysfunction in the FMR1 premutation. | Q46091324 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | molecular medicine | Q3523816 |
| P304 | page(s) | 338 | |
| P577 | publication date | 2018-08-27 | |
| P1433 | published in | Frontiers in Genetics | Q2499875 |
| P1476 | title | Impact of FMR1 Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins | |
| P478 | volume | 9 |
Search more.